A carregar...
Bevacizumab (Avastin)
Bevacizumab is a humanized monoclonal antibody that was the first FDA approved therapy designed to inhibit angiogenesis. This paper will review the mechanism of action and clinical role of this antiangiogenic agent.
Na minha lista:
| Publicado no: | AJNR Am J Neuroradiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Neuroradiology
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7964163/ https://ncbi.nlm.nih.gov/pubmed/20037132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A1987 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|